CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![clinical-trial-tech-ai-GettyImages-2226144959]( "State Of Clinical Trial Technology: The AI Inflection Point")
State Of Clinical Trial Technology: The AI Inflection PointDigital maturity gaps are widening in clinical research. Connected workflows speed insights and execution, while manual processes leave organizations increasingly behind.
-
![Machine Learning-AI-GettyImages-2236865789]( "The Next Competitive Advantage In Clinical Trials Is Execution Intelligence")
The Next Competitive Advantage In Clinical Trials Is Execution IntelligenceAI fails in clinical trials when decision-making is messy. To win, sponsors must fix their "execution blind spot" by structuring how work happens, letting AI turn hidden patterns into strategy.
-
![GettyImages-2213157127-drug-formulation-discovery-pipette-liquid-vial]( "Expedite Drug Development With An Integrated CDMO-CRO Model")
Expedite Drug Development With An Integrated CDMO-CRO ModelFrom optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.
-
![esource-data-GettyImages-2198084779]( "Sponsor-Provided Source Templates: Your Questions Answered")
Sponsor-Provided Source Templates: Your Questions AnsweredSee how centralized eSource improves trial operations through faster startup, better data quality, and real‑time protocol guidance. An expert Q&A offers practical tips for sponsors, sites, and CROs.
-
![Futuristic data-GettyImages-1325172964]( "Navigating The Post-Capture Era Of Clinical Trials")
Navigating The Post-Capture Era Of Clinical TrialsLiberating data through structured workflow management is the key to evolving clinical trials from a series of administrative hurdles into a high-speed engine for medical innovation.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Changing The Clinical Feasibility Game With AI1/22/2026
AI is only as good as the data it’s built upon. Our customized AI platforms are constructed on a foundation of trustworthy, carefully curated data to produce detailed, expert-driven responses.
-
Drilling Down On Diversity And Feasibility12/8/2025
A mid-sized contract research organization (CRO) sought help with writing clinical trial diversity action plans and assessing feasibility for therapeutic areas outside its usual scope.
-
Accelerating Clinical Data Review With Traceable Workflows12/3/2025
Clinical data review needs centralized access and traceable workflows. Leveraging AI-automation and real-time collaboration drives faster, better-informed decisions and reduced compliance risk.
-
Rescuing Data Integrity: A Swift Transition And Quality Transformation11/14/2025
Uncover how this collaboration supported timely progress toward key study milestones, enabling smoother execution and more dependable output across data management and statistical activities.
-
Effect Of Etrasimod On Immune Cell Subsets In Colonic Tissue9/25/2025
Etrasimod selectively modulates S1P receptors to reduce inflammation and immune cell trafficking to the gut, showing promise in treating moderate to severe ulcerative colitis.
CENTRAL LABORATORIES PRODUCTS & SERVICES
Avance Clinical’s data management team has gained a world-class reputation for accuracy, precision, and quality of their biostatistics and pharmacokinetic (PK) analysis.
Ergomed’s Meticulous Risk-Based Quality Management Approach
As a pioneer in providing comprehensive support for your clinical research, Ergomed champions an innovative Risk-Based Quality Management (RBQM) approach. This forward-thinking strategy ensures the highest patient safety standards, regulatory compliance, and data reliability. Ergomed’s proactive approach to managing clinical trials tackles clinical research complexity head-on.
Seamlessly integrated with Curebase’s ePRO/eCOA suite, our EDC enables hybrid and site-based studies that users will love and that streamline all of your data collection into a single, modern experience.
Trial@home, CHDR’s dedicated strategy for off-site clinical trials, enables investigators to collect information as trial participants go about their day to day activities.
It’s about time.
Modern ePRO/eCOA.
Solved.
Don’t wait a lifetime to launch a study that’s just “good enough”. Build and design a data collection experience that patients and sites will love to use.
CENTRAL LABORATORIES SOLUTIONS
- The Big Impact Of Medable AI
- Leading The Way In Patient Payments
- Elevating Cardiovascular Research With eCOA And Sensors
- How AI Is Setting A New Standard In Clinical Development
- Signant SmartSignals® Advisory
- Technology Solutions And Services Tailored For Emerging Biopharma
- Intelligent Trials - Diversity
- Oncology Solutions
- Accelerate Approval Of Novel Therapies
- Balancing Compliance Among The Shifting Sands Of Pharmaceutical Data Privacy Regulations
VIDEOS
- Keeping Your Trials In Motion And Use AI Where It Makes Sense
- Streamline Data Entry With EHR-To-EDC Software
- Revolutionize Data Access With An AI Powered Custom Listing Generator
- How AI-Enhanced CAPA Systems Cut Non-Conformances By Targeting Root Causes
- The Industry’s First And Only Unified Platform For RWE Generation
NEWS
- Altasciences Announces Chris Perkin Appointed To Board Of Directors; Marie-Hélène Raigneau Appointed Chief Executive Officer
- AI Agent Enhances Principal Investigator Oversight Of eCOA Data
- Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes
- Univo IRB And The Patient View Announce Partnership
- Avance Clinical Launches Diversity In STEM Scholarships Across Australia And North America
- Lindus Health And Quotient Sciences Partner To Accelerate Drug Development From First-In-Human To Pivotal Trials
- Integrating Lyft Healthcare As An Affordable On-Demand Transportation Provider For Clinical Trial Participants: A Move Towards Enhanced Patient Experience
- Yoncare s.r.o. Partners With Block Clinical Inc. To Deliver EU-Centric Clinical Trial Participant Travel And Payment Services In Europe
- Block Clinical Discusses Patient Travel Support With Panel Members
- Quotient Sciences And Intrepid Labs Form Strategic Partnership To Accelerate AI-Guided Formulation Development
- One App To Simplify The Clinical Trial Journey
- Avance Clinical Showcases Early Phase Expertise And The Australian Advantage For EU Biotechs At BIO-Europe Vienna
- Meet Avance Clinical At SCOPE Summit 2026 In Orlando, Florida
- Signant Health Appoints Internationally Recognized Cognitive Assessment Expert John Harrison To Further Advance Innovation In CNS Clinical Trials
- Avance Clinical Launches Renal And Cardiometabolic Center Of Excellence To Optimize Patient Recruitment To Elevate Study Success
- Avance Clinical Unveils Dedicated CNS Center Of Excellence For Expert Clinical Trial Services In Neuroscience
- Suvoda Expands EU Patient Travel with Bolt Partnership
- Avance Clinical Launches Dedicated Center Of Excellence To Accelerate Early Phase Biotech Trials
- Castor Catalyst: Launching Self-Driving Clinical Trials With Google Cloud AI
- Almac Trial Coordinator Launched In $48 Million Investment To Advance Integrated eClinical Technologies
- Quotient Sciences And Biorasi Partner To Accelerate Early Phase Clinical Trials To Patient Proof-Of-Concept
- Biorasi Unveils New Website To Drive Sponsor Success With Biotech-Centric Strategies And Modular CRO Solutions
- Suvoda And Greenphire Complete Brand Integration With Unified Website And Social Media Presence
- Avance Clinical Accelerates Time To Pivotal Milestones For More Than 700 Emerging Biotechs
- Avance Clinical Attends Reception Welcoming Australia's US Ambassador To North Carolina Governor's Executive Mansion In Raleigh, N.C.
- Avance Clinical Strengthens Korea Focus: Seoul Meeting Highlights Growth, Partnerships, And Regional Collaboration
- "Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns
- ISPOR Real-World Evidence Summit 28-30 September 2025, Tokyo, Japan
- Ametris Expands Collaborative Research Project To Investigate Digital Measures Of Physical Function For Drug Development in Obesity
- Quotient Sciences And CPI To Accelerate RNA Drug Development With Joint Venture